Published in PLoS One on January 02, 2008
Mesenchymal stromal cells: current understanding and clinical status. Stem Cells (2010) 4.79
Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc (2008) 1.98
Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc (2011) 1.66
Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells (2008) 1.46
Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol (2012) 1.45
How to track cellular aging of mesenchymal stromal cells? Aging (Albany NY) (2010) 1.34
Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. J Cell Mol Med (2008) 1.27
Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair. Biochem Biophys Res Commun (2009) 1.14
Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells. Neoplasia (2009) 1.09
Stem cells and regenerative medicine in lung biology and diseases. Mol Ther (2012) 1.08
Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy. BMC Cancer (2008) 1.04
Mesenchymal stem cells: angels or demons? J Biomed Biotechnol (2011) 1.04
Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells. Tissue Eng Part A (2010) 1.03
Utility of a bacterial infection model to study epithelial-mesenchymal transition, mesenchymal-epithelial transition or tumorigenesis. Oncogene (2013) 1.02
Quality of Cell Products: Authenticity, Identity, Genomic Stability and Status of Differentiation. Transfus Med Hemother (2010) 1.00
Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours. PLoS One (2013) 0.99
Immunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy. Adv Pharm Bull (2013) 0.96
p53 in stem cells. World J Biol Chem (2011) 0.95
Targeting metabolism to induce cell death in cancer cells and cancer stem cells. Int J Cell Biol (2013) 0.94
Stem cells and regenerative medicine: accomplishments to date and future promise. Ther Deliv (2010) 0.90
Toward personalized cell therapies by using stem cells: seven relevant topics for safety and success in stem cell therapy. J Biomed Biotechnol (2012) 0.89
The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells. Cancer Gene Ther (2014) 0.86
Human adipose tissue-derived stem cells cultured in xeno-free culture condition enhance c-MYC expression increasing proliferation but bypassing spontaneous cell transformation. Stem Cell Res Ther (2015) 0.84
Autologous platelet-rich plasma: a biological supplement to enhance adipose-derived mesenchymal stem cell expansion. Tissue Eng Part C Methods (2014) 0.83
Raman spectroscopy for grading of live osteosarcoma cells. Stem Cell Res Ther (2015) 0.82
Human CD34+ progenitor cells freshly isolated from umbilical cord blood attenuate inflammatory lung injury following LPS challenge. PLoS One (2014) 0.81
Harnessing the immunomodulatory and tissue repair properties of mesenchymal stem cells to restore β cell function. Curr Diab Rep (2012) 0.80
Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse. Stem Cells Dev (2016) 0.78
Mesenchymal stem cell-derived microparticles: a promising therapeutic strategy. Int J Mol Sci (2014) 0.77
Gastritis promotes an activated bone marrow-derived mesenchymal stem cell with a phenotype reminiscent of a cancer-promoting cell. Dig Dis Sci (2013) 0.77
Effects of bone marrow-derived mesenchymal stem cells transfected with survivin on pulmonary fibrosis in mice. Exp Ther Med (2015) 0.76
Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase. Stem Cell Res Ther (2013) 0.76
Extracellular vesicles derived from mesenchymal stromal cells may possess increased therapeutic potential for acute kidney injury compared with conditioned medium in rodent models: A meta-analysis. Exp Ther Med (2016) 0.76
Bone Regeneration Using the Freshly Isolated Autologous Stromal Vascular Fraction of Adipose Tissue in Combination With Calcium Phosphate Ceramics. Stem Cells Transl Med (2016) 0.76
Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture. Clin Sarcoma Res (2015) 0.75
Effects of Serial Passage on the Characteristics and Cardiac and Neural Differentiation of Human Umbilical Cord Wharton's Jelly-Derived Mesenchymal Stem Cells. Stem Cells Int (2015) 0.75
Hypoxic Conditioned Medium From Human Adipose-Derived Stem Cells Promotes Mouse Liver Regeneration Through JAK/STAT3 Signaling. Stem Cells Transl Med (2016) 0.75
Isolation, Characterization, and Multipotent Differentiation of Mesenchymal Stem Cells Derived from Meniscal Debris. Stem Cells Int (2016) 0.75
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A (1996) 29.54
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
Cell-cycle checkpoints and cancer. Nature (2004) 13.19
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60
Applying the principles of stem-cell biology to cancer. Nat Rev Cancer (2003) 8.95
Cancer stem cells: models and concepts. Annu Rev Med (2007) 8.06
The RB and p53 pathways in cancer. Cancer Cell (2002) 8.02
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol (2004) 6.61
limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics (2004) 6.04
Modelling the molecular circuitry of cancer. Nat Rev Cancer (2002) 5.43
Retracted Spontaneous human adult stem cell transformation. Cancer Res (2005) 4.95
Rules for making human tumor cells. N Engl J Med (2002) 4.84
Sarcoma derived from cultured mesenchymal stem cells. Stem Cells (2006) 3.40
INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res (2005) 3.08
Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells (2005) 2.52
Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene (2004) 2.47
Coordinated regulation of life and death by RB. Nat Rev Cancer (2003) 2.39
Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. Proc Natl Acad Sci U S A (2007) 2.34
Telomerase and cancer. Hum Mol Genet (2001) 2.28
Telomerase activity in human cancer. Curr Opin Oncol (1996) 2.13
Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev (2004) 1.81
Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging. Genes Dev (2004) 1.71
Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy (2005) 1.70
Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci U S A (2000) 1.69
Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. Cancer Res (2003) 1.64
Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood (2006) 1.63
Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res (2007) 1.58
MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. Stem Cells (2001) 1.51
Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res (2006) 1.48
Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res (2005) 1.41
Immortalization of primary human prostate epithelial cells by c-Myc. Cancer Res (2005) 1.30
Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line. Cancer Res (2005) 1.07
Overexpression of human DNA polymerase mu (Pol mu) in a Burkitt's lymphoma cell line affects the somatic hypermutation rate. Nucleic Acids Res (2004) 1.07
Epigenetic down-regulation of ARF expression is a selection step in immortalization of human fibroblasts by c-Myc. Mol Cancer Res (2007) 1.06
Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression. Am J Pathol (1998) 1.04
Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. Carcinogenesis (1999) 0.96
Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16INK4A promoter in colon carcinoma cell lines. Nucleic Acids Res (2005) 0.95
Telomerase promoter reprogramming and interaction with general transcription factors in the human mesenchymal stem cell. Regen Med (2006) 0.90
t(3;11) translocation in treatment-related acute myeloid leukemia fuses MLL with the GMPS (GUANOSINE 5' MONOPHOSPHATE SYNTHETASE) gene. Blood (2000) 0.89
Association of p16(INK4a) and pRb inactivation with immortalization of human cells. Carcinogenesis (2002) 0.88
Spontaneous immortalization of human epidermal cells with naturally elevated telomerase. J Invest Dermatol (2006) 0.87
Constitutional t(3;11)(p21;q23) in a family, including one member with lymphoma: establishment of novel cell lines with this translocation. Cancer Genet Cytogenet (2000) 0.78
Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A (2005) 15.46
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun (2011) 5.95
Retracted Spontaneous human adult stem cell transformation. Cancer Res (2005) 4.95
A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron (2012) 2.72
EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting. Cell (2010) 2.54
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat Genet (2006) 2.33
c-Jun is a negative regulator of myelination. J Cell Biol (2008) 2.27
Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J (2003) 2.21
The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. EMBO J (2004) 2.15
The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med (2004) 2.11
Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc Natl Acad Sci U S A (2006) 1.70
Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum Mol Genet (2004) 1.60
Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors. Genome Res (2011) 1.60
A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res (2004) 1.44
EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Cancer Res (2005) 1.37
Cancer epigenetics and methylation. Science (2002) 1.31
Gold glyconanoparticles as new tools in antiadhesive therapy. Chembiochem (2004) 1.25
Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells. Blood (2002) 1.22
Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis. FASEB J (2002) 1.21
Cell size regulation in mammalian cells. Cell Cycle (2007) 1.21
Retraction: Spontaneous human adult stem cell transformation. Cancer Res (2010) 1.21
Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations. Oncogene (2004) 1.13
Cancer genes hypermethylated in human embryonic stem cells. PLoS One (2008) 1.12
Novel interfering bifunctional molecules against the CCR5 coreceptor are efficient inhibitors of HIV-1 infection. Mol Ther (2003) 1.09
SOCS up-regulation mobilizes autologous stem cells through CXCR4 blockade. Blood (2006) 1.09
A preclinical model for the analysis of genetically modified human skin in vivo. Hum Gene Ther (2002) 1.08
Overexpression of human DNA polymerase mu (Pol mu) in a Burkitt's lymphoma cell line affects the somatic hypermutation rate. Nucleic Acids Res (2004) 1.07
Selective inactivation of p27(Kip1) in hematopoietic progenitor cells increases neointimal macrophage proliferation and accelerates atherosclerosis. Blood (2003) 1.06
Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction. Mol Ther (2004) 1.06
Human mesenchymal stem cell transformation is associated with a mesenchymal-epithelial transition. Exp Cell Res (2007) 1.05
Generation of GABAergic and dopaminergic interneurons from endogenous embryonic olfactory bulb precursor cells. Development (2006) 1.01
Cell senescence abrogates the therapeutic potential of human mesenchymal stem cells in the lethal endotoxemia model. Stem Cells (2014) 1.01
Dedifferentiated adult articular chondrocytes: a population of human multipotent primitive cells. Exp Cell Res (2004) 1.01
Ras/Raf/ERK signalling and NF1. Cell Cycle (2004) 1.00
Extracellular growth factors and mitogens cooperate to drive mitochondrial biogenesis. J Cell Sci (2009) 0.99
Age-dependent depletion of human skin-derived progenitor cells. Stem Cells (2009) 0.99
Interleukin-6 deficiency affects bone marrow stromal precursors, resulting in defective hematopoietic support. Blood (2003) 0.96
Plasma raltegravir exposure influences the antiviral activity and selection of resistance mutations. AIDS Res Hum Retroviruses (2011) 0.94
A role for DNA polymerase mu in the emerging DJH rearrangements of the postgastrulation mouse embryo. Mol Cell Biol (2008) 0.93
Altered hematopoiesis in mice lacking DNA polymerase mu is due to inefficient double-strand break repair. PLoS Genet (2009) 0.93
Functional interaction between the Ser/Thr kinase PKL12 and N-acetylglucosamine kinase, a prominent enzyme implicated in the salvage pathway for GlcNAc recycling. J Biol Chem (2001) 0.93
NF1 loss disrupts Schwann cell-axonal interactions: a novel role for semaphorin 4F. Genes Dev (2008) 0.93
Structure of the human protein kinase MPSK1 reveals an atypical activation loop architecture. Structure (2008) 0.92
Polymerase mu is up-regulated during the T cell-dependent immune response and its deficiency alters developmental dynamics of spleen centroblasts. Eur J Immunol (2005) 0.91
Injury signals cooperate with Nf1 loss to relieve the tumor-suppressive environment of adult peripheral nerve. Cell Rep (2013) 0.91
Dissecting the contribution of p16(INK4A) and the Rb family to the Ras transformed phenotype. Mol Cell Biol (2003) 0.90
Single-step, multiple retroviral transduction of human T cells. J Gene Med (2002) 0.89
Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients--impact of HIV subtypes and prior raltegravir experience. Antiviral Res (2011) 0.88
miR-335 correlates with senescence/aging in human mesenchymal stem cells and inhibits their therapeutic actions through inhibition of AP-1 activity. Stem Cells (2014) 0.87
Essential function for ErbB3 in breast cancer proliferation. Breast Cancer Res (2004) 0.87
A novel germ line-specific gene of the phosducin-like protein (PhLP) family. A meiotic function conserved from yeast to mice. J Biol Chem (2002) 0.86
Gene control in germinal differentiation: RNF6, a transcription regulatory protein in the mouse sertoli cell. Mol Cell Biol (2002) 0.86
Cascade of transcriptional induction and repression during IL-2 deprivation-induced apoptosis. Immunol Lett (2007) 0.86
Increase in mitochondrial biogenesis, oxidative stress, and glycolysis in murine lymphomas. Free Radic Biol Med (2008) 0.85
Prevalence and characteristics of attaching and effacing strains of Escherichia coil isolated from diarrheic and healthy sheep and goats. Am J Vet Res (2002) 0.85
Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells. Stem Cells (2014) 0.84
A comparison of targeting performance of oncoretroviral versus lentiviral vectors on human keratinocytes. Hum Gene Ther (2003) 0.84
Changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16. Pharm Res (2008) 0.84
Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meeting. Acta Neuropathol (2011) 0.83
Wiskott-Aldrich syndrome protein is needed for vaccinia virus pathogenesis. J Virol (2005) 0.83
Bone microenvironment signals in osteosarcoma development. Cell Mol Life Sci (2015) 0.83
Nucleocytoplasmic shuttling of STK16 (PKL12), a Golgi-resident serine/threonine kinase involved in VEGF expression regulation. Exp Cell Res (2005) 0.83
Loss of anchorage in checkpoint-deficient cells increases genomic instability and promotes oncogenic transformation. J Cell Sci (2009) 0.83
Glycodendritic structures based on Boltorn hyperbranched polymers and their interactions with Lens culinaris lectin. Bioconjug Chem (2003) 0.83
Neurofibroma development in NF1--insights into tumour initiation. Trends Cell Biol (2009) 0.82
Increased learning and brain long-term potentiation in aged mice lacking DNA polymerase μ. PLoS One (2013) 0.81
Successful treatment of propofol-induced priapism with distal glans to corporal cavernosal shunt. Urology (2009) 0.81
Highly efficient lentiviral-mediated human cytokine transgenesis on the NOD/scid background. Blood (2003) 0.81
Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses. Pharmacogenet Genomics (2014) 0.80
Aspects of cell growth control illustrated by the Schwann cell. Curr Opin Cell Biol (2012) 0.80
Predictors of occult bacteremia in young febrile children in the era of heptavalent pneumococcal conjugated vaccine. Eur J Emerg Med (2009) 0.79
Characteristics of adult stem cells. Adv Exp Med Biol (2012) 0.79
Deficient p27 phosphorylation at serine 10 increases macrophage foam cell formation and aggravates atherosclerosis through a proliferation-independent mechanism. Arterioscler Thromb Vasc Biol (2011) 0.78
Update from the 2013 International Neurofibromatosis Conference. Am J Med Genet A (2014) 0.78
Hijacking the ERK signaling pathway: Mycobacterium leprae shuns MEK to drive the proliferation of infected Schwann cells. Sci STKE (2005) 0.77
Complement anaphylatoxins C3a and C5a induce a failing regenerative program in cardiac resident cells. Evidence of a role for cardiac resident stem cells other than cardiomyocyte renewal. Springerplus (2012) 0.77
Loss of Rb cooperates with Ras to drive oncogenic growth in mammalian cells. Curr Biol (2012) 0.76
Inducible model for beta-six-mediated site-specific recombination in mammalian cells. Nucleic Acids Res (2006) 0.76
In vivo site-specific recombination using the beta-rec/six system. Biotechniques (2008) 0.76
A genetic screen for anchorage-independent proliferation in mammalian cells identifies a membrane-bound neuregulin. PLoS One (2010) 0.75
Treating leprosy: an Erb-al remedy? Trends Pharmacol Sci (2007) 0.75
ZAP-70 upregulation in transformed B cells after early pre-BI cell transplant into NOD/SCID mice. Oncogene (2005) 0.75
Clinical and analytical characteristics and short-term evolution of enteroviral meningitis in young infants presenting with fever without source. Pediatr Emerg Care (2012) 0.75
Redox and complexation chemistry of the Cr(VI)/Cr(V)-D-galacturonic acid system. Dalton Trans (2004) 0.75
Erratum: changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16. Pharm Res (2011) 0.75
Absence of hematopoiesis from transplanted olfactory bulb neural stem cells. Eur J Neurosci (2004) 0.75
Efficient cell reprogramming using bioengineered surfaces. Adv Healthc Mater (2012) 0.75